Minocycline Extended Release Tablets Side Effects
Please note - some side effects for Minocycline Extended Release Tablets may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
Minocycline Extended Release Tablets Side Effects - for the Professional
Minocycline Extended Release Tablets
Because clinical trials are conducted under prescribed conditions, adverse reaction rates observed in the clinical trial may not reflect the rates observed in practice. However, adverse reaction information from clinical trials provides a basis for identifying the adverse events that appear to be related to drug use.
Adverse events reported in clinical trials for Minocycline HCl Extended Release Tablets are described below in Table 2.
Table 2 – Selected Treatment-Emergent Adverse Events in at least 1% of Clinical Trial Subjects
| Adverse Event |
Minocycline HCl Extended Release Tablets (1 mg/kg) N=674(%) |
PLACEBO N=364(%) |
| At least one treatment-emergent event | 379(56) | 197(54) |
| Headache | 152(23) | 83(23) |
| Fatigue | 62(9) | 24(7) |
| Dizziness | 59(9) | 17(5) |
| Pruitus | 31(5) | 16(4) |
| Malaise | 26(4) | 9(3) |
| Mood alteration | 17(3) | 9(3) |
| Somnolence | 13(2) | 3(1) |
| Urticaria | 10(2) | 1(0) |
| Tinnitus | 10(2) | 5(1) |
| Arthralgia | 9(1) | 2(0) |
| Vertigo | 8(1) | 3(1) |
| Dry mouth | 7(1) | 5(1) |
| Myalgia | 7(1) | 4(1) |
Adverse reactions not observed in the clinical trials, but that have been reported with minocycline hydrochloride use in a variety of indications include:
Skin and hypersensitivity reactions: fixed drug eruptions, balanitis, erythema multiforme, Stevens-Johnson syndrome, anaphylactoid purpura, photosensitivity, pigmentation of skin and mucous membranes, hypersensitivity reactions, angioneurotic edema, anaphylaxis.
Autoimmune conditions: polyarthralgia, pericarditis, exacerbation of systemic lupus, pulmonary infiltrates with eosinophilia, transient lupus-like syndrome.
Central nervous system: pseudotumor cerebri, bulging fontanels in infants, decreased hearing.
Endocrine: thyroid discoloration, abnormal thyroid function.
Oncology: papillary thyroid cancer.
Oral: glossitis, dysphagia, tooth discoloration.
Gastrointestinal: enterocolitis, pancreatitis, hepatitis, liver failure.
Renal: reversible acute renal failure.
Hematology: hemolytic anemia, thrombocytopenia, eosinophilia.
Preliminary studies suggest that use of minocycline may have deleterious effects on human spermatogenesis.
TopDisclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
